COVIDIG (COVID-19 Hyper-ImmunoGlobulin)

NCT04555148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: GC5131
OTHER: Placebo

Sponsor

Green Cross Corporation